Abstract Aim: The durability of occlusion post endovenous laser therapy (EVLT) for varicose veins is linked to the magnitude of energy delivered to the vein and consequently increasing amounts of energy are employed. The aim of this study is to establish whether increasing the energy results in greater periprocedural morbidity or complications. Methods: Linear and logistic regression models were built to study the effect of energy delivery on outcome. The models controlled for age, gender, BMI, pre-operative quality of life and vein dimension. The outcomes were pain and analgesia requirement in week 1, change in disease specific quality of life (Aberdeen varicose vein questionnaire (AVVQ), change in generic quality of life (Short Form-36 (SF-36) and Euroqol (EQ5D)at week 1 and 6 and complication rates. The sample size calculation established that 115 patients would be required to detect any significant relationship. Results: 232 patients were included. The mean (range) age was 50 (18e83) years. 63% were women. The mean (range) energy delivery was 89.8 (44.5e158.4) J/cm. There was no significant effect on any outcome related to increasing energy delivery. Conclusion: Up to 160J/cm, increasing energy delivery has no significant effect upon the morbidity or complications of EVLT for superficial venous insufficiency. ª
Introduction
Endovenous laser therapy (EVLT) is a relatively new, but popular and promising treatment for varicose veins.
1e11 A meta-analysis suggests that EVLT produces significantly better saphenous ablation on ultrasonography up to 3 years than conventional surgery, foam sclerotherapy and radiofrequency ablation. 12 There is however still room for improvement as treatment failure on duplex ultrasonography still occurs in 1 of 20 saphenous trunks treated. Residual and recurrent disease negates some of the quality of life benefit of treatment and is unpopular with patients. Davies found that 71% of patients want full treatment of their varicose veins in a single visit and over 90% are concerned about the risk of recurrence. 13 Several independent research groups have established the magnitude of energy delivery to be the most important predictor of success 14e16 and increasing energy delivery has resulted in improved occlusion rates. 17, 18 Commonly energy deliveries of around 20e60 J/cm or equivalent fluence calculations have been used, but the current best evidence points to improved results at energies higher than this and many providers now use 80e100 J/cm. Despite this, 100% success remains an elusive goal. The reluctance to increase energy delivery further is most likely due to concerns that this may result in increased morbidity and complications from the procedure. There is however, no evidence that this is the case, when EVLT is performed using tumescent anaesthetic solution.
Surgeons within our department have been gradually increasing the energy density utilised since the advent of EVLT and deliveries of >100 J/cm are now the norm. The aim of this paper is to establish whether there is any evidence that increasing the energy density has any effect upon post-procedural pain, quality of life or complication rates.
Methods
This data is taken from the EVLT arms of non-blinded randomised controlled trials (NCT00759434 and NCT00841178) 9, 10, 19 and non-randomised pilot study 6 which was approved by the local research ethics committee and the institutional research and development department. Patients presenting to a single tertiary referral vascular surgical department with symptomatic varicose veins were assessed for suitability for trial participation.
Inclusion criteria were primary, symptomatic, unilateral varicose veins, with isolated sapheno-femoral junction (SFJ) or sapheno-popliteal junction (SPJ) incompetence, leading to great saphenous vein (GSV) or small saphenous vein reflux respectively on venous duplex with a vein diameter !3 mm. Incompetence was defined as reflux !1 s on spectral-Doppler analysis.
Exclusion criteria were deep venous incompetence on duplex and inability to give informed consent to trial participation.
Patients were included in the studies after giving informed written consent. All EVLT procedures were performed under local tumescent anaesthesia in a dedicated procedure room within the outpatients department. Patients were marked pre-operatively using duplex ultrasound. Skin preparation and draping were performed prior to percutaneous cannulation of the GSV or the small saphenous vein with the patient in the reverse Trendelenburg position. Cannulation was performed at the lowest point of demonstrable reflux. A 5F catheter was introduced into the vein using the Seldinger technique, and its tip was accurately positioned at the SFJ/SPJ using ultrasound. The patient was then placed in the Trendelenburg position, and perivenous tumescent local anaesthetic infiltrated along the vein. Total local anaesthetic did not exceed the recommended maximum safe dose per patient. A sterile baretipped 600 mm laser fibre was introduced via the catheter for laser ablation of the GSV. Endovenous laser energy was delivered using an 810 nm diode laser generator (Angiodynamics Ò , Queensbury, NY, USA). Surface varicosities and incompetent perforators were marked pre-operatively in the dependant position and concomitant phlebectomies were performed via stab incisions made over varicose tributaries, which were avulsed using a Kocherised mosquito clip or vein hook. These incisions were then closed with Steri-stripsä (3M, MN, USA). Perforators were divided and ligated through a 1.5 cm incision, which was then closed using an absorbable subcuticular suture. Cotton wool, gauze and elastic compression dressings were then applied. These were later replaced by a 20e30 mm Hg full-length medical compression stocking. Compression was applied for 6 weeks in total. Patients were discharged with analgesics (diclofenac 50 mg tds) to be taken regularly for 1 week and paracetamol 1g qds for breakthrough pain.
All patients were seen immediately pre-and post-op by the same research nurse, who provided the same instructions: elevation of the leg whilst at rest, mobilise as much as possible and return to work as soon as they feel able to do so, avoid driving, returning only when they can safely perform emergency manoeuvres and after discussion with their insurers (A time period of 2 weeks was suggested). A 24 h contact number was also given for advice or help.
Post-operative assessment was performed at 1 week and 6 weeks in a dedicated clinic.
Outcomes
Patients were given a diary in which to record daily visual analogue pain scores for the first post-operative week. The scales consisted of 7 unmarked 10 cm long lines labelled at one end as "No pain at all" (Score 0) and "Worst Imaginable Pain" at the other (Score 10). Patients marked these lines with a cross and this position was measured and recorded to the nearest millimetre.
In the same diary, patients noted the quantity of breakthrough analgesic medication required daily for the first week and the exact time taken to return to normal activities and to work in days.
Quality of life was measured 1 week and 6 weeks postoperatively, and the pre-operative scores subtracted to give a change in QoL at each time point. The instruments used were as follows:
Generic QoL; SF-36, which utilises 36 items to derive 8 domains each scored from 0 (worst possible) to 100 (best possible). The 4 physical domains were analysed; Physical function, Physical Role, Bodily Pain and General health. Generic QoL; EQ5D, which transforms responses to 5 domain questions, into a global index using a time trade off tariff, scored on a scale of À0.5 (worst score) to 1.0 (best score).
Both SF-36 and EQ5D have been validated for use in patients with varicose veins 20e29 and generic quality of life should be used to as both a measure of efficacy and the morbidity of varicose vein treatment.
Disease Specific QoL; Aberdeen Varicose Veins Questionnaire (AVVQ). This instrument has been shown to be reliable, valid and responsive 23, 25, 29 and records the specific impact of venous disease on patient's quality of life and is scored from 0 (no impact) to a theoretical maximum of 100.
Post-operative complications were noted during clinic follow-up. Particular problems where were sought included sensory disturbance, phlebitis, pigmentation, infection, haematoma and symptoms suggestive of deep vein thrombosis (DVT).
Analysis
All data was recorded into a secure dedicated database (Microsoft Access, Redmond, WA, USA) and analysis performed utilising SPSS (Chicago, IL, USA). Data was analysed through the construction of linear and logistic regression models.
As stated above, the outcome measures were postprocedural pain and analgesia requirement, QoL and complication rates. The primary predictor variable of interest was the linear energy delivery in Joules per centimetre (J/cm). The other independent predictor variables were age, gender, body mass index, the radius and length of the treated vein and pre-operative QoL (Aberdeen varicose vein questionnaire, EQ5D and physical domains of SF-36).
These were included within the models, so their effect could be controlled. Some authors calculate energy delivery taking into account both length and diameter. Controlling for the radius within these models allows these results to be comparable. Although the QoL outcomes are the change in scores, rather than the absolute scores post-procedure, baseline scores were entered into the model. This is because it was unknown whether differing scores at baseline would respond with differing magnitudes to treatment. For example would a patient with chronic back pain notice a similar incremental change in their total bodily pain score as someone with no pain at all before EVLT? This effect, where present, was therefore also controlled.
Linear regression models were produced for continuous outcomes. If the continuous outcomes were not normally distributed, they were transformed using standard mathematical techniques. Statistical significance was set at <0.050 (a Z 0.05). T-tests of the estimated b values allowed significance level calculation of the contribution of an individual predictor to the model's predictive ability. Effect sizes and the proportion of variance in the outcome due to the energy delivery alone were calculated. The models were produced via the method of "forced entry." This allows the retention of methodological control of the modal and is thought to reduce the effect of random sampling variation within the data and produce replicable results. 30 All predictor variables are continuous, with a variance >0. All outcomes are continuous, independent and not constrained. No significant multicollinearity was observed and there are no known correlations between these predictors and external variables. Residual values Logistic regression models were produced for binary outcomes. In this case the individual contribution of the predictors is assessed by chi squared testing of the Wald statistic. The Odds ratio (95% confidence interval) was calculated for the effect of energy delivery alone on the outcome. As with linear regression, the "forced entry" method was used; linearity of the logit and the independence of errors was confirmed. Sufficient data was available for all combinations of variables and multicollinearity was excluded.
Results
232 patients are included in this analysis. The mean (range) age was 50 (18e83) years. 63% were women. The mean (range) energy delivery was 89.8 (44.5e158.4) J/cm. The mean (range) diameter of the vein segment treated was 7.4 (3.0e16.4) mm (assuming uniformity). There was no statistical difference between the energy given to men or women p Z 0.404 (t-test) and therefore no further genderspecific analysis was performed. Baseline clinical severity scores and quality of life are shown in Table 1 .
There is no statistically significant relationship between the energy and the magnitude of post-procedural pain (Table 2) , or the requirement for supplementary analgesia (Table 3 ) during the first week.
Increasing energy also has no effect upon the number of days taken to return to work or to other activities ( Table 2) .
At 6 weeks, patients receiving higher energy deliveries score higher on the AVVQ. This was of borderline statistical significance (p Z 0.050). There is an effect size of 0.18, accounting for 3.1% of the variance at this time point. There was no significant relationship at 1 week and increasing energy has no effect upon the post-procedural generic QoL (Table 4) .
Complications were uncommon and therefore were insufficient to allow meaningful further detailed analysis (Table 5) .
Discussion
This is the first paper to look in depth upon the effects of the magnitude of energy delivery upon the morbidity of EVLT. One would expect that increasing the magnitude of energy delivery to the vein would increase the magnitude of tissue damage created, increasing both pain and swelling, alongside analgesia requirement. This should then have an impact upon quality of life, reducing mobility and general health perception. Patients would take longer to recover. Moreover, transmission of thermal energy beyond the vein should, in theory damage surrounding structures resulting in higher complication rates.
Our data does not support this theorem (within the range of energy utilized). Increasing energy had no effect upon pain or analgesia requirements. The effect of energy upon AVVQ scores at 6 weeks is of borderline statistical significance and doubtful clinical significance; energy accounts for just 3.1% of the variation. We have previously found that generic QoL analysis is more sensitive to the QoL changes associated with periprocedural morbidity than AVVQ 9 and yet there was no difference seen in either of the instruments analysed. It follows therefore that there was no effect upon recovery times. The sample size used in this analysis is double that required for testing the significance of an individual predictor, and so it is unlikely that any significant relationship has been missed.
Complication rates were low, supporting the evidence that EVLT is a very safe procedure. 12, 32, 33 We believe that our results are explained by the use of tumescent local anaesthetic. Accurate and meticulous infiltration of local anaesthetic around the vein causes hydro-dissection of the surrounding tissues away from the vein and the laser fibre. This fluid collapses the vein around the fibre and acts as a heat sink, reducing the transmission of thermal energy by convection and conduction beyond the vein wall. The 810 nm photons from this laser are primarily absorbed by haemoglobin within the blood, 34 minimizing the transmission of radiant energy beyond the vein, also trapping the heat where it is needed: inside the vein. This may not be the case with longer wavelengths, which are primarily absorbed by water, and may therefore be transmitted to the heat sink and possibly beyond.
One criticism of this study is that although all patients underwent some concomitant treatment (phlebectomy and/ or perforator ligation), the extent of these procedures could not be controlled between individuals. However, these procedures maximize the quality of life benefits of treatment and achieves the much desired aim of one-stop treatment. 10, 35, 36 This study therefore aims to reflect true clinical practice with the aim of allowing the results to be generalized.
Conclusion
In experienced hands EVLT is safe and effective. Using an 810 nm laser, increasing linear energy delivery up to 160 J/ cm from currently accepted levels appears safe and results in no measurable additional post operative morbidity. Studies now need to focus upon the optimal energy required to result in 100% closure rates and achieve durable one-stop treatment, first time, every time.
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